Research ArticleOriginal Article
Open Access

The remission rate, metabolic changes, and quality of life assessment among patients with type 2 diabetes post-bariatric surgery in Riyadh, Saudi Arabia

A cross-sectional study

Lina I. Alnajjar, Mohammed A. Alzaben, Atheer A. Alghamdi, Munirah.O. Alomani, Maha S. Abbas, Rahaf F. Altammami, Sara A. Alabdullatif, Aljawharah K. Bin Rokan, Amira M. Youssef and Alaa A. Alhubaishi
Saudi Medical Journal July 2023, 44 (7) 694-702; DOI: https://doi.org/10.15537/smj.2023.44.7.20230080

References

  1. 1.↵
    1. Powell-Wiley TM,
    2. Poirier P,
    3. Burke LE, et al.
    Obesity and cardiovascular disease: A Scientific statement from the American Heart Association. Circulation 2021; 143: e984–e1010.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Ward ZJ,
    2. Willett WC,
    3. Hu FB,
    4. Pacheco LS,
    5. Long MW,
    6. Gortmaker SL.
    Excess mortality associated with elevated body weight in the USA by state and demographic subgroup: A modelling study. EClinicalMedicine 2022; 48: 101429.
    OpenUrl
  3. 3.↵
    1. English WJ,
    2. Williams DB.
    Metabolic and bariatric surgery: An effective treatment option for obesity and cardiovascular disease. Prog Cardiovasc Dis 2018; 61: 253–269.
    OpenUrl
  4. 4.↵
    1. Affinati AH,
    2. Esfandiari NH,
    3. Oral EA,
    4. Kraftson AT.
    Bariatric surgery in the treatment of type 2 diabetes. Curr Diab Rep 2019; 19: 156.
    OpenUrl
  5. 5.↵
    1. Conte C,
    2. Lapeyre-Mestre M,
    3. Hanaire H,
    4. Ritz P.
    Diabetes remission and relapse after bariatric surgery: a Nationwide population-based study. Obes Surg 2020; 30: 4810–4820.
    OpenUrl
  6. 6.↵
    1. Gentileschi P,
    2. Bianciardi E,
    3. Benavoli D,
    4. Campanelli M.
    Metabolic surgery for type II diabetes: an update. Acta Diabetol 2021; 58: 1153–1159.
    OpenUrl
  7. 7.↵
    American Diabetes Association. Obesity management for the treatment of type 2 diabetes. Diabetes Care 2017; 40: S57–S63.
    OpenUrlFREE Full Text
  8. 8.↵
    1. Rubino F,
    2. Nathan DM,
    3. Eckel RH,
    4. Schauer PR,
    5. Alberti KGMM,
    6. Zimmet PZ, et al.
    Metabolic surgery in the treatment algorithm for type 2 diabetes: A Joint Statement by International Diabetes Organizations. Diabetes Care 2016; 39: 861–877.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Zheng Y,
    2. Ley SH,
    3. Hu FB.
    Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018; 14: 88–98.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Araújo J,
    2. Cai J,
    3. Stevens J.
    Prevalence of optimal metabolic health in American Adults: National Health and Nutrition Examination survey 2009–2016. Metab Syndr Relat Disord 2019; 17: 46–52.
    OpenUrl
  11. 11.↵
    1. Aljulifi MZ.
    Prevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council countries. Saudi Med J 2021; 42: 481–490.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Salem V,
    2. AlHusseini N,
    3. Abdul Razack HI,
    4. Naoum A,
    5. Sims OT,
    6. Alqahtani SA.
    Prevalence, risk factors, and interventions for obesity in Saudi Arabia: A systematic review. Obes Rev 2022; 23: e13448.
    OpenUrl
  13. 13.↵
    1. Al-Omar HA,
    2. Alshehri A,
    3. Abanumay A,
    4. Alabdulkarim H,
    5. Alrumaih A,
    6. Eldin MS, et al.
    The impact of obesity in Saudi Arabia: Healthcare Resource Use and costs associated with obesity-related complications. Adv Ther 2023; 40: 1430–1443.
    OpenUrl
  14. 14.↵
    1. Cawley J,
    2. Biener A,
    3. Meyerhoefer C,
    4. Ding Y,
    5. Zvenyach T,
    6. Smolarz BG, et al.
    Direct medical costs of obesity in the United States and the most populous states. J Manag Care Spec Pharm 2021; 27:354–366.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Okunogbe A,
    2. Nugent R,
    3. Spencer G,
    4. Ralston J,
    5. Wilding J.
    Economic impacts of overweight and obesity: current and future estimates for eight countries. BMJ Global Health 2021; 6: e006351.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Ji Y,
    2. Lee H,
    3. Kaura S,
    4. Yip J,
    5. Sun H,
    6. Guan L, et al.
    Effect of bariatric surgery on Metabolic Diseases and underlying mechanisms. Biomolecules 2021; 11: 1582.
    OpenUrl
  17. 17.↵
    1. Eisenberg D,
    2. Shikora SA,
    3. Aarts E,
    4. Aminian A,
    5. Angrisani L,
    6. Cohen RV, et al.
    2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for metabolic and bariatric surgery. Surg Obes Relat Dis 2022;18: 1345–1356.
    OpenUrl
  18. 18.↵
    1. Lauren BN,
    2. Lim F,
    3. Krikhely A,
    4. Taveras EM,
    5. Woo Baidal JA,
    6. Bellows BK, et al.
    Estimated cost-effectiveness of medical therapy, sleeve gastrectomy, and gastric bypass in patients with severe obesity and type 2 diabetes. JAMA Network Open 2022; 5: e2148317.
    OpenUrl
  19. 19.↵
    1. Sierżantowicz R,
    2. Ładny JR,
    3. Lewko J.
    Quality of life after Bariatric surgery—a systematic review. Int J Environ Res Public Health 2022; 19: 9078.
    OpenUrl
  20. 20.↵
    1. Ahmed A,
    2. Alanazi W,
    3. Ahmed R, et al.
    The influences of bariatric surgery on hemoglobin A1c in a sample of obese patients in Saudi Arabia. Diabetes Metab Syndr Obes 2018; 11: 271–276.
    OpenUrl
  21. 21.↵
    World Health Organization. WHOQOL-BREF : introduction, administration, scoring and generic version of the assessment : field trial version, December 1996. [Updated 1996; Accessed 9 August 2018]. Available from: https://apps.who.int/iris/handle/10665/63529
  22. 22.↵
    American Diabetes Association. 6. Glycemic targets: Standards of Medical Care in Diabetes—2019. Diabetes Care 2019; 42: S61–S70.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    International Diabetes Federation. Recommendations For Managing Type 2 Diabetes In Primary Care. 2017 [cited 2020 Aug 28]. Available from: https://www.idf.org/e-library/guidelines/128-idf-clinical-practice-recommendations-for-managing-type-2-diabetes-in-primary-care.html
  24. 24.↵
    1. Miras AD,
    2. Ravindra S,
    3. Humphreys A, et al.
    Metabolic Changes and Diabetes Microvascular Complications 5 Years After Obesity Surgery. Obes Surg 2019; 29: 3907–3911.
    OpenUrlPubMed
  25. 25.↵
    1. Purnell JQ,
    2. Dewey EN,
    3. Laferrère B,
    4. Selzer F,
    5. Flum DR,
    6. Mitchell JE, et al.
    Diabetes remission status during seven-year follow-up of the longitudinal assessment of bariatric surgery study. J Clin Endocrinol Metab 2021; 106: 774–788.
    OpenUrl
  26. 26.↵
    1. Elgenaied I,
    2. El Ansari W,
    3. Elsherif MA,
    4. Abdulrazzaq S,
    5. Qabbani AS,
    6. Elhag W.
    Factors associated with complete and partial remission, improvement, or unchanged diabetes status of obese adults 1 year after sleeve gastrectomy. Surg Obes Relat Dis 2020; 16: 1521–1530.
    OpenUrl
  27. 27.↵
    1. Maclellan WC,
    2. Johnson JM.
    Laparoscopic gastric bypass: still the gold standard? Surgical Clinics 2021; 101: 161–75.
    OpenUrl
  28. 28.↵
    1. Hofsø D,
    2. Fatima F,
    3. Borgeraas H, et al.
    Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial. Lancet Diabetes Endocrinol 2019; 7: 912–924.
    OpenUrl
  29. 29.↵
    1. Bouchard P,
    2. Tchervenkov J,
    3. Demyttenaere S,
    4. Court O,
    5. Andalib A.
    Safety and efficacy of the sleeve gastrectomy as a strategy towards kidney transplantation. Surg Endosc 2020; 34: 2657–64.
    OpenUrl
  30. 30.↵
    1. Yazed AlRuthia 1 2,
    2. Ibrahim Sales 1,
    3. Haya Almalag 1,
    4. Monira Alwhaibi 1 3,
    5. Latifa Almosabhi 1,
    6. Ahmed A Albassam, et al
    . The Relationship Between Health-Related Quality of Life and Trust in Primary Care Physicians Among Patients with Diabetes. Clin Epidemiol 2020; 12: 143–151.
    OpenUrl
  31. 31.↵
    1. Aly S,
    2. Hachey K,
    3. Pernar LI.
    Gender disparities in weight loss surgery. Mini-invasive Surg 2020; 4: 21.
    OpenUrl
  32. 32.↵
    1. Zhang J.
    The Effects of Conformity on Women’s Body Images Under Different Social Norms and Different Cultures. In2021 4th International Conference on Humanities Education and Social Sciences (ICHESS 2021); 2021 Dec 24; Atlantis Press SARL; 2021.
  33. 33.↵
    1. Gobbens RJJ,
    2. Remmen R.
    The effects of sociodemographic factors on quality of life among people aged 50 years or older are not unequivocal: comparing SF-12, WHOQOL-BREF, and WHOQOL-OLD. Clin Interv Aging2019; 14: 231–239.
  34. 34.↵
    1. Gerber P,
    2. Gustafsson UO,
    3. Anderin C,
    4. Johansson F,
    5. Thorell A.
    Effect of age on quality of life after gastric bypass: data from the Scandinavian Obesity Surgery Registry. Surg Obes Relat Dis 2022;18: 1313–1322.
    OpenUrl
  35. 35.↵
    1. Ahmed AE,
    2. Alanazi WR,
    3. ALMuqbil BI,
    4. AlJohi WA,
    5. AlRasheed BA,
    6. AlBuraikan DA, et al
    . Impact of age on postoperative complications following bariatric surgery. Qatar Med J 2019; 2019: 11.
  36. 36.↵
    1. Naif Al-Enazi
    . A needs assessment of bariatric surgery services in Saudi Arabia. Saudi J Obesity 2017; 5: 15–21.
    OpenUrl
  37. 37.↵
    1. Fultang J,
    2. Chinaka U,
    3. Rankin J,
    4. Bakhshi A,
    5. Ali A.
    Preoperative bariatric surgery predictors of type 2 diabetes remission. J Obes Metab Syndr 2021; 30:104.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords